All infectious mononucleosis articles

News

Start-up EBViously announces its launch

2024-12-18T10:48:00Z

EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV).